506 related articles for article (PubMed ID: 28179508)
1. Two-step enhanced cancer immunotherapy with engineered
Zheng JH; Nguyen VH; Jiang SN; Park SH; Tan W; Hong SH; Shin MG; Chung IJ; Hong Y; Bom HS; Choy HE; Lee SE; Rhee JH; Min JJ
Sci Transl Med; 2017 Feb; 9(376):. PubMed ID: 28179508
[TBL] [Abstract][Full Text] [Related]
2. Synergistic cancer immunotherapy utilizing programmed Salmonella typhimurium secreting heterologous flagellin B conjugated to interleukin-15 proteins.
Zhang Y; Tan W; Sultonova RD; Nguyen DH; Zheng JH; You SH; Rhee JH; Kim SY; Khim K; Hong Y; Min JJ
Biomaterials; 2023 Jul; 298():122135. PubMed ID: 37148758
[TBL] [Abstract][Full Text] [Related]
3. Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy.
Mett V; Komarova EA; Greene K; Bespalov I; Brackett C; Gillard B; Gleiberman AS; Toshkov IA; Aygün-Sunar S; Johnson C; Karasik E; Bapardekar-Nair M; Kurnasov OV; Osterman AL; Stanhope-Baker PS; Morrison C; Moser MT; Foster BA; Gudkov AV
Oncogene; 2018 Jan; 37(4):439-449. PubMed ID: 28967901
[TBL] [Abstract][Full Text] [Related]
4. Visualized Cancer Immunotherapy with Engineered Salmonella typhimurium.
Sun Y; Zheng JH
Methods Mol Biol; 2022; 2521():283-294. PubMed ID: 35733004
[TBL] [Abstract][Full Text] [Related]
5. Flagellin enhances tumor-specific CD8⁺ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model.
Nguyen CT; Hong SH; Sin JI; Vu HV; Jeong K; Cho KO; Uematsu S; Akira S; Lee SE; Rhee JH
Vaccine; 2013 Aug; 31(37):3879-87. PubMed ID: 23831323
[TBL] [Abstract][Full Text] [Related]
6. Nucleoside Diphosphate Kinase-3 (
Flentie K; Gonzalez C; Kocher B; Wang Y; Zhu H; Marasa J; Piwnica-Worms D
Mol Cancer Res; 2018 Jun; 16(6):986-999. PubMed ID: 29523766
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer.
Rhee SH; Im E; Pothoulakis C
Gastroenterology; 2008 Aug; 135(2):518-28. PubMed ID: 18538140
[TBL] [Abstract][Full Text] [Related]
8. Flagellin expression enhances Salmonella accumulation in TLR5-positive macrophages.
Metcalfe HJ; Best A; Kanellos T; La Ragione RM; Werling D
Dev Comp Immunol; 2010 Aug; 34(8):797-804. PubMed ID: 20188752
[TBL] [Abstract][Full Text] [Related]
9. A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity.
Lee SE; Kim SY; Jeong BC; Kim YR; Bae SJ; Ahn OS; Lee JJ; Song HC; Kim JM; Choy HE; Chung SS; Kweon MN; Rhee JH
Infect Immun; 2006 Jan; 74(1):694-702. PubMed ID: 16369026
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors.
Marshall NA; Galvin KC; Corcoran AM; Boon L; Higgs R; Mills KH
Cancer Res; 2012 Feb; 72(3):581-91. PubMed ID: 22158905
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria.
Feuillet V; Medjane S; Mondor I; Demaria O; Pagni PP; Galán JE; Flavell RA; Alexopoulou L
Proc Natl Acad Sci U S A; 2006 Aug; 103(33):12487-92. PubMed ID: 16891416
[TBL] [Abstract][Full Text] [Related]
12. TLR5 Ligand-Secreting T Cells Reshape the Tumor Microenvironment and Enhance Antitumor Activity.
Geng D; Kaczanowska S; Tsai A; Younger K; Ochoa A; Rapoport AP; Ostrand-Rosenberg S; Davila E
Cancer Res; 2015 May; 75(10):1959-1971. PubMed ID: 25795705
[TBL] [Abstract][Full Text] [Related]
13. Flagellin-induced tolerance of the Toll-like receptor 5 signaling pathway in polarized intestinal epithelial cells.
Sun J; Fegan PE; Desai AS; Madara JL; Hobert ME
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G767-78. PubMed ID: 17138965
[TBL] [Abstract][Full Text] [Related]
14. Flagellin-dependent TLR5/caveolin-1 as a promising immune activator in immunosenescence.
Lim JS; Nguyen KC; Nguyen CT; Jang IS; Han JM; Fabian C; Lee SE; Rhee JH; Cho KA
Aging Cell; 2015 Oct; 14(5):907-15. PubMed ID: 26223660
[TBL] [Abstract][Full Text] [Related]
15. Tumor Microenvironment-Regulating Immunosenescence-Independent Nanostimulant Synergizing with Near-Infrared Light Irradiation for Antitumor Immunity.
Uthaman S; Pillarisetti S; Hwang HS; Mathew AP; Huh KM; Rhee JH; Park IK
ACS Appl Mater Interfaces; 2021 Feb; 13(4):4844-4852. PubMed ID: 33486952
[TBL] [Abstract][Full Text] [Related]
16. Flagellin suppresses experimental asthma by generating regulatory dendritic cells and T cells.
Shim JU; Lee SE; Hwang W; Lee C; Park JW; Sohn JH; Nam JH; Kim Y; Rhee JH; Im SH; Koh YI
J Allergy Clin Immunol; 2016 Feb; 137(2):426-35. PubMed ID: 26303344
[TBL] [Abstract][Full Text] [Related]
17. Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apoptotic pathways.
Zeng H; Wu H; Sloane V; Jones R; Yu Y; Lin P; Gewirtz AT; Neish AS
Am J Physiol Gastrointest Liver Physiol; 2006 Jan; 290(1):G96-G108. PubMed ID: 16179598
[TBL] [Abstract][Full Text] [Related]
18. Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-kappa B and proinflammatory gene program activation in intestinal epithelial cells.
Tallant T; Deb A; Kar N; Lupica J; de Veer MJ; DiDonato JA
BMC Microbiol; 2004 Aug; 4():33. PubMed ID: 15324458
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 5-deficient mice have dysregulated intestinal gene expression and nonspecific resistance to Salmonella-induced typhoid-like disease.
Vijay-Kumar M; Aitken JD; Kumar A; Neish AS; Uematsu S; Akira S; Gewirtz AT
Infect Immun; 2008 Mar; 76(3):1276-81. PubMed ID: 18195036
[TBL] [Abstract][Full Text] [Related]
20. Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium.
Guo Y; Chen Y; Liu X; Min JJ; Tan W; Zheng JH
Cancer Lett; 2020 Jan; 469():102-110. PubMed ID: 31666180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
